1887

Abstract

Coxsackievirus B3 (CB3) is a well known cause of acute heart muscle disease in humans and experimental animals. After virus is cleared from the heart, a subacute myocarditis or cardiomyopathy may ensue and these conditions are thought to be due to host immune response. During the acute phase of myocarditis, however, the pathogenesis of myocardial fibre destruction remains uncertain. One theory proposing an immune mechanism is based on the 2 to 3 day delay in pathological changes observed after peak virus titres in the heart and their chronological synchrony with the development of cytotoxic T lymphocyte (CTL) activity in the spleen of infected animals (Khatib ., 1980; Woodruff & Woodruff, 1974). Moreover, adoptively transferred, Cr-labelled sensitized T cells are re-routed to the heart at about the time when myocardial fibre damage becomes apparent by light microscopy (Reyes ., 1984).

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-68-12-2981
1987-12-01
2022-01-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/68/12/JV0680122981.html?itemId=/content/journal/jgv/10.1099/0022-1317-68-12-2981&mimeType=html&fmt=ahah

References

  1. Alter B. J., Bach F. M. 1982; Histocompatibility and isoenzyme differences in commercially supplied Balb/c mice. Science 217:379–381
    [Google Scholar]
  2. Berger M. L., Blanden R. V. 1981; The T lymphocytes in infectious pathology. Pathology, Research and Practice 171:128–141
    [Google Scholar]
  3. Gatmaiton B. G., Chason I. L., Lerner A. M. 1970; Augmentation of the virulence of murine coxsackie virus B3 myocarditis by exercise. Journal of Experimental Medicine 131:1121–1136
    [Google Scholar]
  4. Gilden D. H., Cole G. A., Monjan A. A., Nathanson N. 1972; Immunopathogenesis of acute nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction of the virus-carrier state in adult mice. Journal of Experimental Medicine 135:860–873
    [Google Scholar]
  5. Grun J. B., Schultz M., Crowell R. L., Landau B. J. 1984; Development of coxsackievirus B-3 induced myocarditis in the absence of specific cytotoxic T cell activity. In Abstracts of the Annual Meeting of the American Society for MicrobiologyT22 Washington, D.C: American Society for Microbiology;
    [Google Scholar]
  6. Gudvangen R. J., Duffey P. S., Paque R. E., Gauntt C. J. 1983; Levamisol exacerbates coxsackievirus B-3 induced murine myocarditis. Infection and Immunity 41:1157–1165
    [Google Scholar]
  7. Guthrie M., Lodge P. A., Huber S. A. 1984; Cardiac injury in myocarditis induced by coxsackievirus group B type 3 in Balb/c mice is mediated by lyt 2+ cytolytic lymphocytes. Cellular Immunology 88:558–567
    [Google Scholar]
  8. Hashimoto I., Komatsu T. 1978; Myocardial changes after infection with coxsackie virus B3 in nude mice. British Journal of Experimental Pathology 59:13–20
    [Google Scholar]
  9. Hashimoto I., Tatsumi M., Nakagawa M. 1983; The role of T lymphocytes in pathogenesis of coxsackievirus B3 heart disease. British Journal of Experimental Pathology 64:497–504
    [Google Scholar]
  10. Herskowitz A., Beisel K. W., Wolfgram L. I., Rose N. R. 1985; Coxsackievirus B3 myocarditis: wide pathologic spectrum in genetically defined inbred strains. Human Pathology 16:671–673
    [Google Scholar]
  11. Huber S. A., Job L. P. 1983; Cellular immune mechanisms in coxsackievirus group B type 3 induced myocarditis. Advances in Experimental Medicine and Biology 161:491–508
    [Google Scholar]
  12. Huber S. A., Lodge P. A. 1984; Coxsackievirus B-3 myocarditis in Balb/c mice: evidence for autoimmunity to myocyte antigens. American Journal of Pathology 116:21–29
    [Google Scholar]
  13. Huber S. A., Job L. p., Woodruff J. F. 1980; Lysis of infected myofibers by coxsackievirus B-3 murine T lymphocytes. American Journal of Pathology 98:681–694
    [Google Scholar]
  14. Huber S. A., Job L. P. 1982; Influence of sex hormone on coxsackie B3 virus infection in Balb/c mice. Cellular Immunology 67:173–189
    [Google Scholar]
  15. Huber S. A., Job L. P., Woodruff J. F. 1984; In vitro culture of coxsackie group B type 3 immune spleen cells on infected endothelial cells and biologic activity of the cultured cells in vivo. Infection and Immunity 43:567–573
    [Google Scholar]
  16. Khatib R., Chason J. L., Silberberg B. K., Lerner A. M. 1980; Age-dependent pathogenicity of group B coxsackieviruses in Swiss Webster mice: infectivity for myocardium and pancreas. Journal of Infectious Diseases 141:394–403
    [Google Scholar]
  17. Kilbourne E. D., Wilson C. B., Perrier D. 1956; The induction of gross myocardial lesions by a coxsackie (pleurodenia) virus and cortisone. Journal of Clinical Investigation 35:362–370
    [Google Scholar]
  18. Lyden D. c., Huber S. A. 1984; Aggravation of coxsackievirus group B type 3 induced myocarditis and increase in cellular immunity to myocyte antigens in pregnant Balb/c mice and animals treated with progesterone. Cellular Immunology 87:462–472
    [Google Scholar]
  19. Melnick J. L., Ledinko N. 1950; Immunologic reactions of coxsackie viruses; neutralization test: technique and application. Journal of Experimental Medicine 92:463–482
    [Google Scholar]
  20. Melnick J. L., Wenner H. A., Phillips C. A. 1979; Enteroviruses: identification of isolates. In Diagnostic procedures for Viral, Rickettsial and Chlamydial Infections, 5th edn. pp 508–514 Lennette E. H., Schmidt N. J. Edited by Washington, D.C.: American Public Health Association;
    [Google Scholar]
  21. O’Connell J. b., Reap E. A., Robinson J. A. 1986; The effects of cyclosporin on acute murine coxsackievirus B3 myocarditis. Circulation 73:353–359
    [Google Scholar]
  22. Paque R. E., Gauntt C. J., Nealon T. J., Trousdale M. D. 1978; Assessment of cell-mediated hypersensitivity against coxsackie B3 virus-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue. Journal of Immunology 120:1672–1678
    [Google Scholar]
  23. Paque R. E., Straus D. c., Nealon T. J., Gauntt C. J. 1979; Fractionation and immunologic assessment of KCl-extracted cardiac antigens in coxsackievirus B-3. Journal of Immunology 123:358–364
    [Google Scholar]
  24. Rager-Zisman B., Allison A. C. 1973; Effects of immunosuppression on coxsackie B-3 virus infection in mice, and passive protection by circulating antibody. Journal of General Virology 19:339–351
    [Google Scholar]
  25. Reed L. J., Muench H. 1938; A simple method of estimating fifty percent endpoints. American Journal of Hygiene 27:493–497
    [Google Scholar]
  26. Reyes M. P., Smith F. E., Lerner A. M. 1984; An enterovirus-induced murine model of an acute dilated-type cardiomyopathy. Intervirology 22:146–155
    [Google Scholar]
  27. Rezkalla S., Khatib G., Khatib R. 1986; Coxsackievirus B3 murine myocarditis: deleterious effects of nonsteroidal anti-inflammatory agents. Journal of Laboratory and Clinical Medicine 107:393–395
    [Google Scholar]
  28. Robinson J. A., O’Connell J. B., Rogers L. M., Major E. O., Gunner R. M. 1981; Coxsackie B3 myocarditis in athymic mice. Proceedings of the Society for Experimental Biology and Medicine 166:80–91
    [Google Scholar]
  29. Roesing T. G., Landau B. J., Crowell R. L. 1979; Limited persistence of viral antigen in coxsackievirus B3 induced heart muscle disease in mice. Proceedings of the Society for Experimental Biology and Medicine 160:382–386
    [Google Scholar]
  30. Schnurr D. P., Schmidt N. J. 1984; Coxsackievirus B3 persistence and myocarditis in NFR nu/nu and +/nu mice. Medical Microbiology and Immunology 173:1–7
    [Google Scholar]
  31. Schnurr D. P., Cao Y., Schmidt N. J. 1984; Coxsackievirus B3 persistence and myocarditis in N :NIH(S) II nu/nu and +/nu mice. Journal of General Virology 65:1197–1201
    [Google Scholar]
  32. Wilson F. M., Lerner A. M. 1978; A cardiomyopathy of Balb/c mice (superimposed infection by coxsackievirus B3). Proceedings of the Society for Experimental Biology and Medicine 157:442–448
    [Google Scholar]
  33. Wolfgram L. J., Beisel K. W., Rose N. R. 1985; Heart-specific autoreactive antibodies following coxsackievirus B3 myocarditis. Journal of Experimental Medicine 161:1112–1121
    [Google Scholar]
  34. Wong D. W., Woodruff J. J., Woodruff J. F. 1977a; Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and virus specificity. Journal of Immunology 118:1159–1164
    [Google Scholar]
  35. Wong D. W., Woodruff J. J., Woodruff J. F. 1977b; Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. II. Characterization of effector cells and demonstration of cytotoxicity against viral-infected myocardium. Journal of Immunology 118:1165–1169
    [Google Scholar]
  36. Wong C. Y., Woodruff J. J., Woodruff J. F. 1977c; Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. III. Role of sex. Journal of Immunology 119:591–597
    [Google Scholar]
  37. Woodruff J. F. 1979; Lack of correlation between neutralizing antibody production and suppression of coxsackievirus B3 replication in target organs: evidence for involvement of mononuclear inflammatory cells in host defence. Journal of Immunology 123:31–36
    [Google Scholar]
  38. Woodruff J. F., Kilbourne E. D. 1970; The influence of quantitated post-weanling under-nutrition on coxsackievirus B3 infection of adult mice. 1. Viral persistence and increased severity of lesions. Journal of Infectious Diseases 121:137–163
    [Google Scholar]
  39. Woodruff J. F., Woodruff J. J. 1974; Involvement of T lymphocytes in the pathogenesis of coxsackievirus B3 heart disease. Journal of Immunology 113:1726–1734
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-68-12-2981
Loading
/content/journal/jgv/10.1099/0022-1317-68-12-2981
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error